Artificial sweeteners seen boosting diabetes risk

Sep 18, 2014

Artificial sweeteners seen boosting diabetes risk

Promoted as an aid to good health, artificial sweeteners may in fact be boosting diabetes risk, said a study Wednesday that urged a rethink of their widespread use and endorsement. Also called noncalorific artificial sweeteners, or NAS, the additives are found in diet sodas, ...

Sep 12, 2014

FDA approves weight-loss drug Contrave

U.S. regulators are greenlighting a new weight-loss drug called Contrave, the third in a string of approvals for anti-obesity treatments. The drug was developed by Orexigen Therapeutics Inc., based in La Jolla, California. The Food and Drug Administration said Thursday that it is approved ...

Jul 8, 2014

U.S. regulators fast-track novel leukemia therapy

U.S. regulators on Monday put an experimental immunotherapy agent on the fast track to market approval, after 89 percent of leukemia patients in early trials saw their cancers disappear. The personalized immunotherapy known as CTL019 was developed by the University of Pennsylvania and was ...

Jul 24, 2013

U.S. regulator cites menthol cigarette risks

The Food and Drug Administration said for the first time Tuesday that menthol-flavored cigarettes appear to pose a greater risk to public health than standard smokes, largely reaffirming the findings of an agency advisory committee two years ago and potentially laying the groundwork for ...